(Q33377436)

26 July 2017

1 reference

title

Heparin-induced thrombocytopenia and recent advances in its therapy (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

Hassan Y

1

1 reference

26 July 2017

Awaisu A

2

1 reference

26 July 2017

Aziz NA

3

1 reference

26 July 2017

Aziz NH

4

1 reference

26 July 2017

Ismail O

5

1 reference

26 July 2017

language of work or name

1 reference

1 December 2007

1 reference

Journal of Clinical Pharmacy and Therapeutics

26 July 2017

published in

1 reference

26 July 2017

volume

32

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

535-544

1 reference

Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin‐induced thrombocytopenia: pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin-induced thrombocytopenia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

New concepts in heparin-induced thrombocytopenia: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Heparin-induced thrombocytopenia in intensive care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Delayed-onset heparin-induced thrombocytopenia and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Newer strategies for the treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2007.00865.X

10.1111/J.1365-2710.2007.00865.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference